During the test phase, the circulating levels of exosomal lncRNA-GC1 and serum CEA were significantly higher in patients with GC (n = 96) compared with those of the HDs (n = 68; P < .001) (Figure 2A and B). The gene discussed is CEACAM5; the disease is gastric cancer.